ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL was reported 50304 times

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NASAL DISCOMFORT 384 0.0484
1 NASAL ULCER 73 0.0458
2 PRODUCT PACKAGE ASSOCIATED INJURY 82 0.0368
3 ESSENTIAL HYPERTENSION 66 0.0360
4 RHINITIS ALLERGIC 155 0.0348
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 36 0.0339
6 ACUTE SINUSITIS 58 0.0336
7 CHRONIC SINUSITIS 115 0.0306
8 RHINALGIA 82 0.0298
9 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 162 0.0297
10 NASAL DRYNESS 176 0.0281
11 NEPHROGENIC ANAEMIA 129 0.0278
12 ANOSMIA 401 0.0277
13 NASAL OEDEMA 47 0.0260
14 SPUTUM INCREASED 56 0.0259
15 HYPERPARATHYROIDISM SECONDARY 63 0.0251
16 NASAL DISORDER 66 0.0248
17 PARANASAL SINUS DISCOMFORT 86 0.0227
18 INFUSION SITE DISCHARGE 39 0.0222
19 OBSTRUCTIVE SLEEP APNOEA SYNDROME 32 0.0219
20 INFUSION SITE PRURITUS 68 0.0215
21 MIDDLE EAR EFFUSION 47 0.0213
22 MULTIPLE ALLERGIES 162 0.0206
23 PRE-EXISTING CONDITION IMPROVED 129 0.0206
24 UPPER-AIRWAY COUGH SYNDROME 168 0.0204
25 SINUS HEADACHE 117 0.0197
26 BILIARY DYSKINESIA 33 0.0194
27 DIASTOLIC DYSFUNCTION 59 0.0191
28 EPISTAXIS 1419 0.0190
29 SINUS OPERATION 45 0.0189
30 REBOUND ACID HYPERSECRETION 56 0.0185
31 NASAL SEPTUM DEVIATION 36 0.0184
32 INFUSION SITE BRUISING 38 0.0176
33 SINUS DISORDER 345 0.0174
34 PHARYNGOLARYNGEAL PAIN 91 0.0171
35 INFUSION SITE HAEMORRHAGE 56 0.0170
36 CANDIDIASIS 68 0.0169
37 SEASONAL ALLERGY 232 0.0164
38 NASAL POLYPS 78 0.0158
39 PULMONARY FUNCTION TEST DECREASED 68 0.0155
40 SPINAL OSTEOARTHRITIS 136 0.0155
41 SLEEP APNOEA SYNDROME 282 0.0148
42 PAROSMIA 111 0.0147
43 INTERVERTEBRAL DISC DEGENERATION 135 0.0146
44 SINUSITIS 1463 0.0143
45 DIVERTICULUM 101 0.0142
46 SNORING 53 0.0140
47 HYPERLIPIDAEMIA 165 0.0138
48 SPINAL COLUMN STENOSIS 64 0.0135
49 RHINITIS 109 0.0135
50 BRONCHITIS CHRONIC 33 0.0135
51 RESPIRATORY SYMPTOM 38 0.0133
52 PHARMACEUTICAL PRODUCT COMPLAINT 343 0.0132
53 EAR CONGESTION 35 0.0129
54 SNEEZING 289 0.0129
55 TRICUSPID VALVE INCOMPETENCE 102 0.0128
56 AGEUSIA 320 0.0128
57 ATELECTASIS 123 0.0127
58 CHOLECYSTITIS CHRONIC 85 0.0127
59 NASAL CONGESTION 745 0.0127
60 CYSTIC FIBROSIS 70 0.0126
61 RADICULOPATHY 33 0.0125
62 INCREASED UPPER AIRWAY SECRETION 64 0.0125
63 SINUS CONGESTION 167 0.0123
64 PARANASAL SINUS HYPERSECRETION 47 0.0123
65 EAR PRURITUS 42 0.0120
66 INFUSION SITE SWELLING 74 0.0117
67 LUMBAR SPINAL STENOSIS 34 0.0116
68 INFUSION SITE ERYTHEMA 98 0.0116
69 IRON DEFICIENCY ANAEMIA 107 0.0116
70 THROMBOPHLEBITIS SUPERFICIAL 35 0.0115
71 ISCHAEMIC CARDIOMYOPATHY 35 0.0114
72 ORTHOPNOEA 36 0.0113
73 SPUTUM DISCOLOURED 106 0.0112
74 VITAMIN D DEFICIENCY 108 0.0111
75 CAROTID ARTERY STENOSIS 38 0.0109
76 FACET JOINT SYNDROME 35 0.0107
77 ASTHMA 1214 0.0107
78 PLANTAR FASCIITIS 36 0.0107
79 EAR DISORDER 49 0.0107
80 EAR DISCOMFORT 109 0.0106
81 HIATUS HERNIA 136 0.0105
82 UPPER RESPIRATORY TRACT INFECTION 485 0.0105
83 DEAFNESS NEUROSENSORY 34 0.0103
84 BURSITIS 125 0.0103
85 DIVERTICULUM INTESTINAL 45 0.0103
86 ROTATOR CUFF SYNDROME 130 0.0101
87 FOOD ALLERGY 78 0.0101
88 ORAL CANDIDIASIS 132 0.0100
89 HAEMORRHAGIC ANAEMIA 44 0.0100
90 BONE LESION 36 0.0100
91 EAR INFECTION 263 0.0099
92 GLUCOSE TOLERANCE IMPAIRED 58 0.0098
93 BRONCHIECTASIS 66 0.0098
94 WHEEZING 580 0.0098
95 EMPHYSEMA 98 0.0097
96 BRONCHITIS 718 0.0097
97 VIRAL UPPER RESPIRATORY TRACT INFECTION 46 0.0097
98 EAR PAIN 187 0.0096
99 ACUTE RESPIRATORY FAILURE 184 0.0096
100 ROSACEA 44 0.0094
101 EXOSTOSIS 86 0.0094
102 RHINORRHOEA 596 0.0092
103 SCOLIOSIS 57 0.0092
104 UMBILICAL HERNIA 43 0.0092
105 MITRAL VALVE INCOMPETENCE 103 0.0091
106 SKIN LACERATION 98 0.0090
107 END STAGE RENAL DISEASE 164 0.0090
108 GASTROOESOPHAGEAL REFLUX DISEASE 719 0.0089
109 AORTIC VALVE INCOMPETENCE 38 0.0089
110 RHINOVIRUS INFECTION 34 0.0087
111 CANDIDA INFECTION 147 0.0087
112 VITAMIN B12 DEFICIENCY 35 0.0086
113 FACIAL PAIN 77 0.0086
114 RESPIRATORY TRACT CONGESTION 137 0.0086
115 MAJOR DEPRESSION 63 0.0086
116 PRODUCTIVE COUGH 410 0.0086
117 INCREASED TENDENCY TO BRUISE 79 0.0086
118 OSTEOPENIA 130 0.0086
119 OBESITY 136 0.0085
120 OESOPHAGEAL CANDIDIASIS 34 0.0085
121 GASTROENTERITIS VIRAL 154 0.0085
122 LOW TURNOVER OSTEOPATHY 34 0.0085
123 PROTEIN TOTAL DECREASED 32 0.0085
124 INTERVERTEBRAL DISC DISORDER 36 0.0084
125 CARPAL TUNNEL SYNDROME 118 0.0084
126 CHRONIC KIDNEY DISEASE 640 0.0084
127 DRY THROAT 85 0.0084
128 INFUSION SITE PAIN 107 0.0083
129 DIABETIC NEUROPATHY 41 0.0083
130 FIBROMYALGIA 200 0.0082
131 NONSPECIFIC REACTION 45 0.0082
132 BREATH SOUNDS ABNORMAL 40 0.0081
133 PERIPHERAL VENOUS DISEASE 33 0.0081
134 DYSPHONIA 468 0.0080
135 THERAPEUTIC RESPONSE UNEXPECTED 359 0.0080
136 DYSPNOEA EXERTIONAL 301 0.0080
137 LUNG NEOPLASM 34 0.0080
138 OSTEOARTHRITIS 337 0.0079
139 TRIGGER FINGER 32 0.0078
140 OBSTRUCTIVE AIRWAYS DISORDER 87 0.0078
141 DRUG ADMINISTRATION ERROR 239 0.0078
142 BUNDLE BRANCH BLOCK LEFT 33 0.0078
143 TONGUE DISCOMFORT 33 0.0078
144 MIDDLE INSOMNIA 145 0.0078
145 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
146 RENAL CYST 61 0.0077
147 CARDIAC MURMUR 66 0.0076
148 TOOTH ABSCESS 77 0.0076
149 ENDOMETRIOSIS 36 0.0075
150 MUSCLE STRAIN 65 0.0075
151 INITIAL INSOMNIA 77 0.0075
152 PULMONARY HYPERTENSION 156 0.0075
153 ECONOMIC PROBLEM 113 0.0074
154 ARTHROPOD BITE 55 0.0074
155 PRODUCT COMPLAINT 187 0.0074
156 THROAT IRRITATION 330 0.0073
157 INTERVERTEBRAL DISC PROTRUSION 160 0.0073
158 TONGUE DISCOLOURATION 32 0.0073
159 SOMNAMBULISM 48 0.0073
160 POST-TRAUMATIC STRESS DISORDER 49 0.0073
161 BREAST MASS 49 0.0073
162 HYPERVOLAEMIA 36 0.0073
163 LIGAMENT SPRAIN 72 0.0073
164 RIGHT VENTRICULAR FAILURE 51 0.0073
165 CARDIAC FLUTTER 47 0.0073
166 ONYCHOCLASIS 50 0.0073
167 LACERATION 68 0.0072
168 LARGE INTESTINE POLYP 50 0.0072
169 PULMONARY MASS 106 0.0071
170 IRON DEFICIENCY 32 0.0071
171 DERMATITIS CONTACT 81 0.0071
172 ARTERIOSCLEROSIS CORONARY ARTERY 47 0.0071
173 APHONIA 99 0.0071
174 HYPERKERATOSIS 39 0.0071
175 MALNUTRITION 79 0.0071
176 HYPERCHOLESTEROLAEMIA 68 0.0070
177 VENTRICULAR EXTRASYSTOLES 73 0.0070
178 HYPOVOLAEMIA 41 0.0070
179 MENISCUS INJURY 43 0.0070
180 CARDIOMEGALY 86 0.0070
181 BACK INJURY 76 0.0070
182 PERIPHERAL VASCULAR DISORDER 36 0.0070
183 PULMONARY CONGESTION 92 0.0070
184 JOINT EFFUSION 48 0.0070
185 FOOD POISONING 37 0.0069
186 IMPAIRED QUALITY OF LIFE 99 0.0069
187 MIGRAINE 657 0.0069
188 INSURANCE ISSUE 105 0.0069
189 COUGH 1918 0.0068
190 HOSPICE CARE 67 0.0068
191 VARICOSE VEIN 35 0.0068
192 ATRIAL FLUTTER 54 0.0068
193 PSEUDOMONAS INFECTION 58 0.0068
194 OROPHARYNGEAL PAIN 626 0.0068
195 HAIR COLOUR CHANGES 84 0.0067
196 BODY HEIGHT DECREASED 72 0.0067
197 RETCHING 143 0.0067
198 ORAL PAIN 150 0.0067
199 TOOTH INFECTION 88 0.0067
200 HAIR DISORDER 55 0.0067
201 GINGIVITIS 36 0.0067
202 VITAMIN D DECREASED 57 0.0067
203 FEELING JITTERY 126 0.0066
204 BENIGN PROSTATIC HYPERPLASIA 34 0.0066
205 LACRIMATION INCREASED 198 0.0065
206 DENTAL CARIES 72 0.0065
207 RENAL FAILURE CHRONIC 50 0.0065
208 WEIGHT FLUCTUATION 68 0.0065
209 CHEST DISCOMFORT 664 0.0065
210 CORONARY ARTERY DISEASE 196 0.0065
211 MUSCULOSKELETAL CHEST PAIN 100 0.0065
212 RESPIRATORY TRACT INFECTION 168 0.0064
213 NECK PAIN 358 0.0064
214 VIRAL INFECTION 213 0.0064
215 THYROID DISORDER 98 0.0064
216 ANHEDONIA 167 0.0063
217 HAIR TEXTURE ABNORMAL 85 0.0063
218 HYSTERECTOMY 55 0.0063
219 NEURALGIA 154 0.0063
220 STRESS FRACTURE 34 0.0063
221 VISUAL DISTURBANCE 36 0.0063
222 NIGHT SWEATS 202 0.0063
223 DEEP VEIN THROMBOSIS 405 0.0062
224 HYPOXIA 219 0.0062
225 PHARYNGITIS 77 0.0062
226 BLEPHAROSPASM 39 0.0062
227 FLUID OVERLOAD 90 0.0062
228 PARAESTHESIA ORAL 89 0.0062
229 RESTLESS LEGS SYNDROME 112 0.0062
230 GINGIVAL PAIN 49 0.0062
231 SCIATICA 98 0.0061
232 OVERWEIGHT 33 0.0061
233 GALLBLADDER DISORDER 109 0.0061
234 TEMPERATURE INTOLERANCE 63 0.0061
235 DECREASED INTEREST 36 0.0061
236 INFUSION SITE EXTRAVASATION 38 0.0061
237 HYPOAESTHESIA ORAL 92 0.0061
238 BRONCHOSPASM 87 0.0061
239 CATARACT 363 0.0061
240 LYMPHOEDEMA 42 0.0061
241 CONCUSSION 47 0.0061
242 SECRETION DISCHARGE 76 0.0061
243 THERMAL BURN 43 0.0061
244 HAEMOPTYSIS 169 0.0061
245 ORAL DISORDER 44 0.0060
246 PRODUCT ADMINISTRATION INTERRUPTED 47 0.0060
247 TENDON DISORDER 39 0.0060
248 PHARYNGEAL OEDEMA 92 0.0060
249 SENSATION OF FOREIGN BODY 50 0.0059
250 PHARYNGITIS STREPTOCOCCAL 64 0.0059
251 HAEMORRHOIDS 115 0.0059
252 CELLULITIS 297 0.0059
253 DIVERTICULITIS 163 0.0059
254 MULTIPLE INJURIES 37 0.0059
255 MUSCLE SPASTICITY 72 0.0059
256 MADAROSIS 68 0.0059
257 FUNGAL INFECTION 195 0.0058
258 HAEMATOCRIT DECREASED 116 0.0058
259 SUPRAVENTRICULAR TACHYCARDIA 56 0.0058
260 IMMUNODEFICIENCY 87 0.0058
261 ECCHYMOSIS 40 0.0058
262 TINNITUS 268 0.0058
263 PAIN IN JAW 165 0.0058
264 RENAL INJURY 173 0.0058
265 TOOTH FRACTURE 64 0.0058
266 GOUT 104 0.0058
267 BLOOD MAGNESIUM DECREASED 50 0.0058
268 DYSGEUSIA 429 0.0058
269 ANXIETY 1630 0.0057
270 TRANSIENT ISCHAEMIC ATTACK 193 0.0057
271 BACK DISORDER 93 0.0057
272 BLOOD TESTOSTERONE DECREASED 39 0.0057
273 ODYNOPHAGIA 34 0.0057
274 GROIN PAIN 50 0.0057
275 STAPHYLOCOCCAL INFECTION 187 0.0057
276 OROPHARYNGEAL DISCOMFORT 51 0.0056
277 NOCTURIA 68 0.0056
278 PANIC ATTACK 204 0.0056
279 VITREOUS FLOATERS 55 0.0056
280 HEAD DISCOMFORT 99 0.0056
281 PERICARDIAL EFFUSION 129 0.0056
282 TENDERNESS 58 0.0056
283 SPINAL COMPRESSION FRACTURE 46 0.0056
284 CATARACT OPERATION 33 0.0056
285 PSYCHOLOGICAL TRAUMA 48 0.0056
286 CHEST PAIN 1030 0.0056
287 EXERCISE TOLERANCE DECREASED 32 0.0056
288 VISUAL FIELD DEFECT 40 0.0055
289 POOR QUALITY SLEEP 119 0.0055
290 RESPIRATION ABNORMAL 38 0.0055
291 EYE PRURITUS 185 0.0055
292 IRRITABLE BOWEL SYNDROME 118 0.0055
293 BONE DISORDER 100 0.0055
294 FOOT FRACTURE 104 0.0055
295 GLAUCOMA 105 0.0054
296 INJURY 383 0.0054
297 SCAB 62 0.0054
298 DRY MOUTH 441 0.0054
299 THROAT TIGHTNESS 147 0.0054
300 COVID-19 PNEUMONIA 64 0.0054
301 EYE INFECTION 61 0.0054
302 PHOTOPSIA 34 0.0054
303 CLOSTRIDIUM DIFFICILE COLITIS 57 0.0054
304 OBSESSIVE-COMPULSIVE DISORDER 43 0.0054
305 OSTEOPOROSIS 220 0.0053
306 POLYP 35 0.0053
307 MICTURITION URGENCY 61 0.0053
308 PNEUMONIA BACTERIAL 49 0.0053
309 URINARY TRACT INFECTION 908 0.0053
310 BLOOD POTASSIUM DECREASED 160 0.0053
311 LUNG INFILTRATION 47 0.0053
312 LYMPHADENOPATHY 188 0.0053
313 LOW DENSITY LIPOPROTEIN INCREASED 41 0.0053
314 TENDONITIS 82 0.0053
315 OEDEMA PERIPHERAL 645 0.0053
316 APPETITE DISORDER 35 0.0053
317 CARDIAC FAILURE CONGESTIVE 424 0.0053
318 LUNG INFECTION 82 0.0053
319 TOOTHACHE 95 0.0052
320 DYSPNOEA 2970 0.0052
321 WOUND INFECTION 57 0.0052
322 OVARIAN CYST 52 0.0052
323 RIB FRACTURE 107 0.0052
324 RESPIRATORY SYNCYTIAL VIRUS INFECTION 45 0.0052
325 FLATULENCE 293 0.0052
326 CHOLECYSTECTOMY 59 0.0052
327 URINARY INCONTINENCE 153 0.0052
328 CONTUSION 497 0.0052
329 DECUBITUS ULCER 42 0.0051
330 TENDON PAIN 39 0.0051
331 DEPRESSION 1171 0.0051
332 PNEUMONIA 1664 0.0051
333 CLOSTRIDIUM DIFFICILE INFECTION 112 0.0051
334 NERVOUSNESS 268 0.0051
335 DRY EYE 256 0.0051
336 TROPONIN INCREASED 39 0.0051
337 CHOLELITHIASIS 168 0.0051
338 INSOMNIA 1364 0.0051
339 ANAL INCONTINENCE 46 0.0051
340 ELECTROCARDIOGRAM ABNORMAL 40 0.0051
341 ARTHRITIS 401 0.0051
342 RENAL TUBULAR NECROSIS 50 0.0051
343 BLOOD TRIGLYCERIDES INCREASED 90 0.0051
344 NERVE COMPRESSION 47 0.0051
345 PALPITATIONS 596 0.0051
346 HERPES SIMPLEX 33 0.0051
347 BALANCE DISORDER 438 0.0051
348 PULMONARY EMBOLISM 481 0.0051
349 HEADACHE 3168 0.0050
350 VERTIGO 307 0.0050
351 HYPERSENSITIVITY 935 0.0050
352 TENDON RUPTURE 62 0.0050
353 GASTRITIS 132 0.0050
354 BLOOD CHOLESTEROL INCREASED 233 0.0050
355 MUSCULOSKELETAL DISCOMFORT 86 0.0050
356 CYST 62 0.0050
357 HYPERSOMNIA 143 0.0050
358 LOCAL SWELLING 87 0.0050
359 BACK PAIN 1157 0.0050
360 FEELING DRUNK 37 0.0050
361 TASTE DISORDER 101 0.0050
362 PRESYNCOPE 121 0.0050
363 BLOOD IRON DECREASED 59 0.0050
364 BIPOLAR DISORDER 54 0.0050
365 PRESCRIBED OVERDOSE 96 0.0050
366 GASTROENTERITIS 72 0.0049
367 BLOOD PRESSURE INCREASED 754 0.0049
368 SCAR 84 0.0049
369 OCULAR DISCOMFORT 55 0.0049
370 POLLAKIURIA 204 0.0049
371 EUPHORIC MOOD 50 0.0049
372 SPINAL DISORDER 46 0.0049
373 OESOPHAGITIS 53 0.0048
374 FLUID RETENTION 246 0.0048
375 INCONTINENCE 51 0.0048
376 NEPHROLITHIASIS 221 0.0048
377 HOT FLUSH 363 0.0048
378 RESPIRATORY DISORDER 144 0.0048
379 PERIPHERAL COLDNESS 66 0.0048
380 CARDIOMYOPATHY 71 0.0048
381 FLANK PAIN 45 0.0048
382 PRODUCT QUALITY ISSUE 652 0.0048
383 HAND FRACTURE 34 0.0048
384 EYE HAEMORRHAGE 64 0.0048
385 COELIAC DISEASE 47 0.0048
386 MUSCLE SPASMS 879 0.0048
387 HEPATOMEGALY 47 0.0048
388 JOINT INJURY 102 0.0048
389 IMPAIRED GASTRIC EMPTYING 65 0.0048
390 DYSPEPSIA 469 0.0048
391 NASOPHARYNGITIS 877 0.0048
392 DYSURIA 175 0.0047
393 HEART RATE INCREASED 471 0.0047
394 HEREDITARY ANGIOEDEMA 51 0.0047
395 DIZZINESS POSTURAL 46 0.0047
396 CONJUNCTIVITIS 88 0.0047
397 CORONARY ARTERY OCCLUSION 65 0.0047
398 SENSORY DISTURBANCE 76 0.0047
399 ATRIAL FIBRILLATION 460 0.0047
400 BLOOD SODIUM DECREASED 89 0.0047
401 EYE DISCHARGE 49 0.0047
402 SMALL INTESTINAL OBSTRUCTION 58 0.0047
403 CONSTIPATION 1027 0.0047
404 DISEASE RECURRENCE 224 0.0047
405 ACTIVITIES OF DAILY LIVING IMPAIRED 93 0.0047
406 PULMONARY ARTERIAL HYPERTENSION 68 0.0047
407 TRANSFUSION 49 0.0047
408 SWOLLEN TONGUE 146 0.0047
409 POST PROCEDURAL INFECTION 38 0.0047
410 RED BLOOD CELL COUNT DECREASED 133 0.0046
411 CYSTITIS 148 0.0046
412 OXYGEN SATURATION DECREASED 261 0.0046
413 LIMB INJURY 126 0.0046
414 GLOMERULAR FILTRATION RATE DECREASED 57 0.0046
415 MUSCULOSKELETAL PAIN 243 0.0046
416 SLEEP DISORDER 327 0.0046
417 BLADDER DISORDER 46 0.0046
418 MENTAL STATUS CHANGES 128 0.0046
419 NEPHROPATHY 43 0.0046
420 PULMONARY HAEMORRHAGE 36 0.0046
421 SWELLING FACE 299 0.0046
422 EOSINOPHIL COUNT INCREASED 38 0.0046
423 JOINT RANGE OF MOTION DECREASED 61 0.0045
424 NEUROPATHY PERIPHERAL 432 0.0045
425 BLOOD ALBUMIN DECREASED 36 0.0045
426 TUBULOINTERSTITIAL NEPHRITIS 85 0.0045
427 UTERINE LEIOMYOMA 33 0.0045
428 PELVIC PAIN 82 0.0045
429 RENAL FAILURE 599 0.0045
430 THINKING ABNORMAL 84 0.0045
431 NERVE INJURY 50 0.0045
432 PULMONARY THROMBOSIS 49 0.0045
433 PLEURAL EFFUSION 273 0.0045
434 BLOOD UREA INCREASED 75 0.0045
435 HYPOTHYROIDISM 143 0.0045
436 DIZZINESS 2227 0.0045
437 ORAL DISCOMFORT 62 0.0045
438 AFFECTIVE DISORDER 35 0.0044
439 LUNG DISORDER 218 0.0044
440 JOINT DISLOCATION 47 0.0044
441 EXTRASYSTOLES 31 0.0044
442 IRRITABILITY 266 0.0044
443 PERIPHERAL SWELLING 681 0.0044
444 PNEUMOTHORAX 70 0.0044
445 PERSONALITY CHANGE 41 0.0044
446 BRAIN FOG 69 0.0044
447 IMMUNE SYSTEM DISORDER 58 0.0044
448 PRURITUS GENERALISED 95 0.0044
449 ANKLE FRACTURE 68 0.0044
450 FEAR 118 0.0044
451 HYPERAESTHESIA 36 0.0044
452 HYPOAESTHESIA 655 0.0044
453 SINUS TACHYCARDIA 62 0.0044
454 LEUKOCYTOSIS 79 0.0044
455 BASAL CELL CARCINOMA 68 0.0044
456 ARTERIOSCLEROSIS 41 0.0044
457 CRYING 158 0.0043
458 URINE OUTPUT DECREASED 38 0.0043
459 FATIGUE 3382 0.0043
460 NAIL DISORDER 38 0.0043
461 BACTERIAL INFECTION 81 0.0043
462 MUSCULAR WEAKNESS 493 0.0043
463 GLOSSODYNIA 97 0.0043
464 FOOT DEFORMITY 48 0.0043
465 MUSCLE DISORDER 35 0.0043
466 FLUSHING 439 0.0043
467 OEDEMA 234 0.0043
468 SLUGGISHNESS 44 0.0043
469 THIRST 77 0.0043
470 OSTEOMYELITIS 78 0.0043
471 MYOCARDIAL ISCHAEMIA 49 0.0043
472 IMPAIRED WORK ABILITY 92 0.0043
473 DEHYDRATION 574 0.0043
474 LOCALISED INFECTION 104 0.0043
475 MOOD SWINGS 137 0.0043
476 HEPATIC STEATOSIS 80 0.0043
477 MEMORY IMPAIRMENT 590 0.0043
478 PHARYNGEAL SWELLING 42 0.0043
479 FURUNCLE 34 0.0043
480 THERAPY CESSATION 220 0.0043
481 DISTURBANCE IN ATTENTION 231 0.0043
482 MYALGIA 727 0.0043
483 TOOTH DISORDER 95 0.0043
484 POST PROCEDURAL COMPLICATION 82 0.0043
485 BLOOD CALCIUM DECREASED 48 0.0043
486 FULL BLOOD COUNT DECREASED 86 0.0043
487 UTERINE PERFORATION 36 0.0042
488 SOMNOLENCE 856 0.0042
489 INFLUENZA 474 0.0042
490 QUALITY OF LIFE DECREASED 57 0.0042
491 GINGIVAL BLEEDING 58 0.0042
492 DEAFNESS 111 0.0042
493 GASTROINTESTINAL INFECTION 38 0.0042
494 ABNORMAL DREAMS 117 0.0042
495 FEELING ABNORMAL 1013 0.0042
496 IMPAIRED DRIVING ABILITY 48 0.0042
497 UPPER LIMB FRACTURE 84 0.0042
498 HYPERTENSION 892 0.0042
499 BLINDNESS TRANSIENT 31 0.0042
500 ANGER 142 0.0042
501 COVID-19 736 0.0042
502 IMMUNOSUPPRESSION 37 0.0042
503 PARAESTHESIA 659 0.0042
504 VISION BLURRED 575 0.0042
505 WRIST FRACTURE 50 0.0042
506 THERAPY CHANGE 41 0.0042
507 GASTRIC DISORDER 143 0.0042
508 PAIN IN EXTREMITY 1227 0.0042
509 ABDOMINAL PAIN UPPER 855 0.0041
510 MASS 58 0.0041
511 SQUAMOUS CELL CARCINOMA 39 0.0041
512 HERPES ZOSTER 238 0.0041
513 WEIGHT DECREASED 1153 0.0041
514 BLOOD THYROID STIMULATING HORMONE INCREASED 38 0.0041
515 TREMOR 685 0.0041
516 ANAPHYLACTIC REACTION 228 0.0041
517 URTICARIA 690 0.0041
518 PELVIC FRACTURE 32 0.0041
519 SWELLING 384 0.0041
520 LETHARGY 236 0.0041
521 PSYCHOMOTOR HYPERACTIVITY 68 0.0041
522 PRODUCT DISTRIBUTION ISSUE 38 0.0041
523 EXPIRED PRODUCT ADMINISTERED 136 0.0041
524 EYE SWELLING 152 0.0041
525 COLD SWEAT 72 0.0041
526 FRUSTRATION TOLERANCE DECREASED 33 0.0041
527 INFLUENZA LIKE ILLNESS 336 0.0041
528 HEART RATE IRREGULAR 92 0.0041
529 FEELING HOT 249 0.0041
530 NODULE 53 0.0041
531 DYSPHAGIA 385 0.0041
532 BURNING SENSATION 284 0.0040
533 BOWEL MOVEMENT IRREGULARITY 31 0.0040
534 CHILLS 473 0.0040
535 UNEVALUABLE EVENT 305 0.0040
536 FALL 1341 0.0040
537 RETINAL DETACHMENT 37 0.0040
538 FEELING COLD 112 0.0040
539 SKIN INFECTION 45 0.0040
540 WEIGHT INCREASED 897 0.0040
541 INTRAOCULAR PRESSURE INCREASED 51 0.0040
542 SENSORY LOSS 32 0.0040
543 KNEE OPERATION 39 0.0040
544 ORTHOSTATIC HYPOTENSION 69 0.0040
545 BLOOD COUNT ABNORMAL 60 0.0040
546 MUSCLE TIGHTNESS 64 0.0039
547 ABDOMINAL DISCOMFORT 662 0.0039
548 DEVICE FAILURE 60 0.0039
549 DYSSTASIA 115 0.0039
550 SINUS BRADYCARDIA 38 0.0039
551 PROCEDURAL PAIN 109 0.0039
552 SPLENOMEGALY 46 0.0039
553 ASPIRATION 43 0.0039
554 EJECTION FRACTION DECREASED 61 0.0039
555 MOOD ALTERED 107 0.0039
556 PNEUMONIA ASPIRATION 98 0.0039
557 DRUG SCREEN POSITIVE 31 0.0039
558 OCULAR HYPERAEMIA 186 0.0039
559 HEAD INJURY 124 0.0039
560 ASTHENIA 1469 0.0039
561 CHOKING 76 0.0039
562 KNEE ARTHROPLASTY 82 0.0039
563 GASTRIC ULCER 74 0.0039
564 PAIN 2389 0.0039
565 POOR QUALITY DEVICE USED 39 0.0039
566 HYPOKALAEMIA 179 0.0039
567 FULL BLOOD COUNT ABNORMAL 41 0.0039
568 HYPERHIDROSIS 499 0.0039
569 PRODUCT SUBSTITUTION ISSUE 223 0.0039
570 PRODUCT USE COMPLAINT 61 0.0039
571 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 113 0.0039
572 DRUG EFFECT INCOMPLETE 140 0.0039
573 EATING DISORDER 82 0.0038
574 DIPLOPIA 100 0.0038
575 ORAL HERPES 75 0.0038
576 ILL-DEFINED DISORDER 233 0.0038
577 STOMATITIS 232 0.0038
578 BLOOD POTASSIUM INCREASED 62 0.0038
579 WHITE BLOOD CELL COUNT INCREASED 146 0.0038
580 ARTHRALGIA 1580 0.0038
581 AMNESIA 247 0.0038
582 ACUTE KIDNEY INJURY 581 0.0038
583 SKIN ULCER 98 0.0038
584 LIMB DISCOMFORT 117 0.0038
585 COAGULOPATHY 63 0.0038
586 BONE PAIN 221 0.0038
587 PARANOIA 65 0.0038
588 INCORRECT DRUG ADMINISTRATION DURATION 106 0.0038
589 NAUSEA 2980 0.0038
590 ABDOMINAL DISTENSION 393 0.0038
591 DIARRHOEA 2427 0.0038
592 THROMBOSIS 302 0.0038
593 PULMONARY OEDEMA 168 0.0037
594 IMPAIRED HEALING 123 0.0037
595 DEFORMITY 35 0.0037
596 HUNGER 52 0.0037
597 RESPIRATORY DISTRESS 103 0.0037
598 LIVER FUNCTION TEST INCREASED 80 0.0037
599 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 265 0.0037
600 LIP SWELLING 124 0.0037
601 SUICIDAL IDEATION 340 0.0037
602 FEMUR FRACTURE 115 0.0037
603 MUSCLE ATROPHY 47 0.0037
604 LABORATORY TEST ABNORMAL 109 0.0037
605 INCORRECT PRODUCT ADMINISTRATION DURATION 80 0.0037
606 HYPOPHAGIA 94 0.0037
607 HEART RATE DECREASED 129 0.0037
608 HERNIA 71 0.0037
609 KIDNEY INFECTION 72 0.0037
610 PHOTOPHOBIA 69 0.0037
611 RASH PRURITIC 197 0.0036
612 INJECTION SITE NODULE 40 0.0036
613 SARS-COV-2 TEST POSITIVE 48 0.0036
614 RENAL FAILURE ACUTE 154 0.0036
615 ADRENAL INSUFFICIENCY 44 0.0036
616 JOINT STIFFNESS 95 0.0036
617 ELECTROLYTE IMBALANCE 42 0.0036
618 PULMONARY FIBROSIS 69 0.0036
619 TYPE 2 DIABETES MELLITUS 121 0.0036
620 ABDOMINAL PAIN 834 0.0036
621 EYE IRRITATION 206 0.0036
622 POOR VENOUS ACCESS 37 0.0036
623 DEPRESSED MOOD 189 0.0036
624 MUSCULOSKELETAL DISORDER 68 0.0036
625 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 196 0.0036
626 BLOOD PRESSURE ABNORMAL 71 0.0036
627 ANOREXIA 46 0.0036
628 FAECES DISCOLOURED 77 0.0035
629 INFECTION 514 0.0035
630 GASTROINTESTINAL PAIN 39 0.0035
631 EYE PAIN 200 0.0035
632 BLOOD ALKALINE PHOSPHATASE INCREASED 88 0.0035
633 APHASIA 107 0.0035
634 TOOTH EXTRACTION 44 0.0035
635 EMOTIONAL DISORDER 109 0.0035
636 PRODUCT ODOUR ABNORMAL 37 0.0035
637 SPEECH DISORDER 185 0.0035
638 CONDITION AGGRAVATED 1073 0.0035
639 RASH PAPULAR 79 0.0035
640 RESPIRATORY FAILURE 257 0.0035
641 DECREASED ACTIVITY 38 0.0035
642 DECREASED APPETITE 817 0.0035
643 MACULAR DEGENERATION 42 0.0035
644 ROAD TRAFFIC ACCIDENT 147 0.0035
645 ARTHROPATHY 195 0.0035
646 DISCOMFORT 214 0.0035
647 UPPER GASTROINTESTINAL HAEMORRHAGE 59 0.0035
648 AUTOIMMUNE DISORDER 34 0.0035
649 SYNCOPE 349 0.0035
650 ABDOMINAL PAIN LOWER 88 0.0035
651 MUSCLE TWITCHING 80 0.0035
652 UROSEPSIS 32 0.0035
653 EYE DISORDER 114 0.0035
654 HEPATIC ENZYME INCREASED 236 0.0035
655 COGNITIVE DISORDER 161 0.0034
656 RECTAL HAEMORRHAGE 148 0.0034
657 NIGHTMARE 119 0.0034
658 ABNORMAL BEHAVIOUR 136 0.0034
659 SPINAL PAIN 40 0.0034
660 WRONG TECHNIQUE IN DRUG USAGE PROCESS 124 0.0034
661 GAIT DISTURBANCE 653 0.0034
662 ERUCTATION 66 0.0034
663 BLISTER 191 0.0034
664 JOINT SWELLING 410 0.0034
665 HIP ARTHROPLASTY 52 0.0034
666 ABSCESS 54 0.0034
667 BODY TEMPERATURE INCREASED 69 0.0034
668 PRODUCT USE ISSUE 635 0.0034
669 BREAST PAIN 36 0.0034
670 PLATELET COUNT INCREASED 44 0.0034
671 GASTROINTESTINAL HAEMORRHAGE 282 0.0034
672 COORDINATION ABNORMAL 47 0.0034
673 WOUND 94 0.0034
674 HAEMOGLOBIN DECREASED 344 0.0033
675 PYREXIA 1158 0.0033
676 RASH MACULAR 117 0.0033
677 DRUG INEFFECTIVE 4382 0.0033
678 PRODUCT TASTE ABNORMAL 45 0.0033
679 INTESTINAL OBSTRUCTION 125 0.0033
680 HEMIPARESIS 56 0.0033
681 DRUG DOSE OMISSION 546 0.0033
682 DERMATITIS 69 0.0033
683 GAIT INABILITY 110 0.0033
684 SEPSIS 367 0.0033
685 BLOOD PRESSURE SYSTOLIC INCREASED 64 0.0033
686 LYMPHOCYTE COUNT DECREASED 58 0.0033
687 CHOLECYSTITIS 39 0.0033
688 GASTROINTESTINAL DISORDER 293 0.0033
689 BLOOD URINE PRESENT 62 0.0033
690 HIP FRACTURE 105 0.0033
691 SKIN DISCOLOURATION 150 0.0033
692 SPINAL OPERATION 40 0.0032
693 MALAISE 1422 0.0032
694 INABILITY TO AFFORD MEDICATION 32 0.0032
695 BLOOD PRESSURE DECREASED 214 0.0032
696 COLITIS 122 0.0032
697 PHOTOSENSITIVITY REACTION 53 0.0032
698 BLOOD PRESSURE FLUCTUATION 77 0.0032
699 INFUSION RELATED REACTION 212 0.0032
700 ECZEMA 167 0.0032
701 VOMITING 1500 0.0032
702 HYPOACUSIS 137 0.0032
703 PRURITUS 1222 0.0032
704 RENAL DISORDER 148 0.0032
705 SKIN LESION 87 0.0032
706 VAGINAL DISCHARGE 32 0.0032
707 HYPOMAGNESAEMIA 44 0.0032
708 ANAEMIA 602 0.0032
709 RASH 1375 0.0032
710 EYELID PTOSIS 32 0.0031
711 ASPARTATE AMINOTRANSFERASE INCREASED 167 0.0031
712 SCRATCH 33 0.0031
713 RASH GENERALISED 81 0.0031
714 MUSCULOSKELETAL STIFFNESS 274 0.0031
715 MENTAL DISORDER 136 0.0031
716 EMOTIONAL DISTRESS 378 0.0031
717 SKIN DISORDER 104 0.0031
718 BACTERAEMIA 37 0.0031
719 PRODUCT DOSE OMISSION IN ERROR 88 0.0031
720 MENORRHAGIA 61 0.0031
721 CONTRAINDICATED PRODUCT ADMINISTERED 94 0.0031
722 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
723 UNRESPONSIVE TO STIMULI 80 0.0031
724 ACCIDENT 37 0.0031
725 SPINAL FRACTURE 62 0.0031
726 INCREASED APPETITE 59 0.0031
727 SURGERY 181 0.0031
728 ILLNESS 318 0.0031
729 ULCER 49 0.0031
730 DISORIENTATION 122 0.0031
731 ADVERSE DRUG REACTION 276 0.0031
732 WHITE BLOOD CELL COUNT DECREASED 332 0.0031
733 MALIGNANT MELANOMA 41 0.0031
734 CONFUSIONAL STATE 494 0.0031
735 DIABETES MELLITUS 233 0.0031
736 CHROMATURIA 69 0.0031
737 LOSS OF CONSCIOUSNESS 391 0.0030
738 FOLLICULITIS 32 0.0030
739 PRODUCT DOSE OMISSION 199 0.0030
740 INJECTION SITE DISCOLOURATION 38 0.0030
741 DYSKINESIA 123 0.0030
742 LIVER FUNCTION TEST ABNORMAL 88 0.0030
743 HALLUCINATION 228 0.0030
744 VISUAL IMPAIRMENT 374 0.0030
745 URINARY RETENTION 100 0.0030
746 SEIZURE 344 0.0030
747 INTERNAL HAEMORRHAGE 34 0.0030
748 ALOPECIA 584 0.0030
749 DRUG EFFECT DECREASED 160 0.0030
750 DRUG PRESCRIBING ERROR 57 0.0030
751 INJECTION SITE PRURITUS 198 0.0030
752 HYPOTENSION 591 0.0029
753 MOUTH ULCERATION 62 0.0029
754 ANGINA PECTORIS 84 0.0029
755 DEVICE RELATED INFECTION 45 0.0029
756 MOBILITY DECREASED 210 0.0029
757 DYSARTHRIA 110 0.0029
758 MENTAL IMPAIRMENT 70 0.0029
759 RASH ERYTHEMATOUS 138 0.0029
760 ACUTE MYOCARDIAL INFARCTION 85 0.0029
761 HEPATIC CIRRHOSIS 54 0.0029
762 ARRHYTHMIA 136 0.0029
763 OSTEONECROSIS OF JAW 71 0.0029
764 INJECTION SITE URTICARIA 70 0.0029
765 GLYCOSYLATED HAEMOGLOBIN INCREASED 72 0.0028
766 VENTRICULAR TACHYCARDIA 47 0.0028
767 RESTLESSNESS 104 0.0028
768 INTENTIONAL DOSE OMISSION 81 0.0028
769 DISABILITY 56 0.0028
770 INJECTION SITE BRUISING 225 0.0028
771 HAEMATOMA 73 0.0028
772 AGGRESSION 141 0.0028
773 TREATMENT NONCOMPLIANCE 154 0.0028
774 DRUG DISPENSING ERROR 43 0.0028
775 ALANINE AMINOTRANSFERASE INCREASED 172 0.0028
776 ADVERSE EVENT 257 0.0028
777 ATAXIA 33 0.0028
778 HYPERGLYCAEMIA 101 0.0028
779 RHEUMATOID ARTHRITIS 314 0.0028
780 TACHYCARDIA 245 0.0028
781 SKIN CANCER 59 0.0027
782 BEDRIDDEN 36 0.0027
783 ILEUS 34 0.0027
784 PRODUCT USE IN UNAPPROVED INDICATION 678 0.0027
785 SICKLE CELL ANAEMIA WITH CRISIS 43 0.0027
786 PANCREATITIS 144 0.0027
787 INTENTIONAL PRODUCT MISUSE 238 0.0027
788 PRODUCT DOSE OMISSION ISSUE 798 0.0027
789 BLOOD CREATININE INCREASED 177 0.0027
790 LOWER LIMB FRACTURE 52 0.0027
791 INTENTIONAL PRODUCT USE ISSUE 237 0.0027
792 ERYTHEMA 556 0.0027
793 HYPOKINESIA 39 0.0027
794 BLOOD GLUCOSE DECREASED 129 0.0027
795 COMPLICATION ASSOCIATED WITH DEVICE 39 0.0027
796 MULTIPLE SCLEROSIS RELAPSE 184 0.0027
797 COLON CANCER 40 0.0027
798 CARDIAC DISORDER 251 0.0027
799 MULTIPLE SCLEROSIS 128 0.0027
800 PANCREATITIS ACUTE 60 0.0027
801 FEEDING DISORDER 54 0.0027
802 ERECTILE DYSFUNCTION 68 0.0026
803 ENCEPHALOPATHY 65 0.0026
804 EXTRA DOSE ADMINISTERED 107 0.0026
805 ADVERSE REACTION 35 0.0026
806 DELUSION 41 0.0026
807 UNDERDOSE 192 0.0026
808 CEREBROVASCULAR ACCIDENT 444 0.0026
809 BLOOD BILIRUBIN INCREASED 70 0.0026
810 GENERALISED OEDEMA 32 0.0026
811 PARALYSIS 37 0.0026
812 BLOOD GLUCOSE INCREASED 486 0.0026
813 MYOCARDIAL INFARCTION 449 0.0026
814 THERAPEUTIC RESPONSE DECREASED 156 0.0026
815 HAEMATURIA 88 0.0026
816 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 520 0.0026
817 DYSMENORRHOEA 34 0.0026
818 PLATELET COUNT DECREASED 273 0.0026
819 VISUAL ACUITY REDUCED 85 0.0026
820 DRY SKIN 341 0.0026
821 INJECTION SITE RASH 78 0.0025
822 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 180 0.0025
823 HAEMATEMESIS 64 0.0025
824 METRORRHAGIA 43 0.0025
825 SUBDURAL HAEMATOMA 36 0.0025
826 PSORIATIC ARTHROPATHY 101 0.0025
827 DIABETES MELLITUS INADEQUATE CONTROL 44 0.0025
828 PRODUCT PHYSICAL ISSUE 50 0.0025
829 CENTRAL NERVOUS SYSTEM LESION 34 0.0025
830 ABASIA 61 0.0025
831 PNEUMONITIS 67 0.0025
832 MOVEMENT DISORDER 79 0.0025
833 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
834 EXPOSURE DURING PREGNANCY 152 0.0024
835 AGITATION 179 0.0024
836 INJECTION SITE ERYTHEMA 302 0.0024
837 BLOOD TEST ABNORMAL 34 0.0024
838 HYPONATRAEMIA 136 0.0024
839 TOOTH LOSS 50 0.0024
840 LYMPHOMA 37 0.0024
841 SKIN EXFOLIATION 201 0.0024
842 ASCITES 70 0.0024
843 APPLICATION SITE PRURITUS 54 0.0024
844 ACCIDENTAL EXPOSURE TO PRODUCT 245 0.0024
845 DEVICE DELIVERY SYSTEM ISSUE 65 0.0024
846 FREQUENT BOWEL MOVEMENTS 64 0.0024
847 DEVICE DISLOCATION 103 0.0024
848 DRUG EFFECT LESS THAN EXPECTED 35 0.0024
849 SKIN HAEMORRHAGE 35 0.0024
850 CONVULSION 135 0.0024
851 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 40 0.0024
852 LOWER RESPIRATORY TRACT INFECTION 107 0.0024
853 WITHDRAWAL SYNDROME 98 0.0023
854 INJECTION SITE WARMTH 48 0.0023
855 HALLUCINATION, AUDITORY 37 0.0023
856 DEMENTIA 65 0.0023
857 PAIN OF SKIN 62 0.0023
858 INCORRECT DOSE ADMINISTERED 523 0.0023
859 CYANOSIS 36 0.0023
860 INJECTION SITE MASS 84 0.0023
861 APPLICATION SITE PAIN 50 0.0023
862 DRUG INTOLERANCE 219 0.0023
863 THERAPEUTIC RESPONSE SHORTENED 75 0.0023
864 PRESCRIBED UNDERDOSE 45 0.0023
865 APPLICATION SITE RASH 31 0.0023
866 NERVOUS SYSTEM DISORDER 70 0.0022
867 DEVICE MALFUNCTION 156 0.0022
868 ACCIDENTAL OVERDOSE 81 0.0022
869 VAGINAL HAEMORRHAGE 96 0.0022
870 HAEMATOCHEZIA 122 0.0022
871 INJECTION SITE HAEMORRHAGE 176 0.0022
872 SKIN FISSURES 43 0.0022
873 BONE LOSS 33 0.0022
874 INJECTION SITE REACTION 151 0.0022
875 OSTEONECROSIS 72 0.0022
876 HALLUCINATION, VISUAL 46 0.0022
877 DEVICE ISSUE 193 0.0021
878 DEVICE BREAKAGE 87 0.0021
879 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 386 0.0021
880 BONE DENSITY DECREASED 67 0.0021
881 THERAPY NON-RESPONDER 96 0.0021
882 MANIA 35 0.0021
883 HYPOGLYCAEMIA 103 0.0021
884 SYSTEMIC LUPUS ERYTHEMATOSUS 75 0.0021
885 HAEMORRHAGE 220 0.0021
886 OFF LABEL USE 1841 0.0021
887 COMPLICATION OF DEVICE REMOVAL 38 0.0021
888 ACNE 159 0.0021
889 INFLAMMATION 108 0.0021
890 BLINDNESS 85 0.0021
891 PLASMA CELL MYELOMA 81 0.0021
892 METASTASES TO BONE 34 0.0021
893 INJECTION SITE PAIN 634 0.0021
894 APPLICATION SITE ERYTHEMA 54 0.0021
895 DISEASE PROGRESSION 243 0.0021
896 SEPTIC SHOCK 88 0.0020
897 PSORIASIS 264 0.0020
898 PALLOR 55 0.0020
899 PRODUCT AVAILABILITY ISSUE 46 0.0020
900 THERAPEUTIC PRODUCT EFFECT DECREASED 90 0.0020
901 MULTIPLE FRACTURES 33 0.0020
902 MELAENA 44 0.0020
903 INJECTION SITE SWELLING 152 0.0020
904 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 46 0.0020
905 JAUNDICE 53 0.0020
906 CARDIAC FAILURE 158 0.0020
907 HOSPITALISATION 298 0.0019
908 METASTASES TO LIVER 34 0.0019
909 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
910 THERAPY INTERRUPTED 136 0.0019
911 PREGNANCY 38 0.0019
912 HYPERKALAEMIA 66 0.0019
913 GENERAL PHYSICAL HEALTH DETERIORATION 217 0.0019
914 BLOOD GLUCOSE ABNORMAL 34 0.0018
915 DRUG EXPOSURE DURING PREGNANCY 62 0.0018
916 NEEDLE ISSUE 53 0.0018
917 NEUTROPHIL COUNT DECREASED 74 0.0018
918 RESPIRATORY ARREST 50 0.0018
919 RENAL IMPAIRMENT 151 0.0018
920 PRODUCT PRESCRIBING ISSUE 39 0.0018
921 COLITIS ULCERATIVE 80 0.0018
922 LUNG NEOPLASM MALIGNANT 73 0.0018
923 PANCYTOPENIA 99 0.0018
924 INTENTIONAL DRUG MISUSE 37 0.0018
925 PRODUCT DISPENSING ERROR 38 0.0017
926 THROMBOCYTOPENIA 193 0.0017
927 BREAST CANCER FEMALE 46 0.0017
928 SEDATION 45 0.0017
929 BRADYCARDIA 91 0.0017
930 PRODUCT PREPARATION ERROR 35 0.0017
931 PSYCHOTIC DISORDER 50 0.0017
932 HYPOCALCAEMIA 32 0.0017
933 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 78 0.0017
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 48 0.0017
935 TARDIVE DYSKINESIA 47 0.0017
936 CARDIAC ARREST 136 0.0016
937 PRODUCT ADMINISTRATION ERROR 33 0.0016
938 ANAPHYLACTIC SHOCK 42 0.0016
939 SKIN IRRITATION 74 0.0016
940 MENSTRUATION IRREGULAR 43 0.0016
941 NO ADVERSE EVENT 286 0.0016
942 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 52 0.0015
943 MEDICATION ERROR 84 0.0015
944 LIVER DISORDER 67 0.0015
945 CARDIO-RESPIRATORY ARREST 63 0.0015
946 NEOPLASM MALIGNANT 100 0.0015
947 DERMATITIS ATOPIC 79 0.0015
948 RHABDOMYOLYSIS 62 0.0015
949 INCORRECT ROUTE OF DRUG ADMINISTRATION 53 0.0015
950 DELIRIUM 51 0.0015
951 CEREBRAL HAEMORRHAGE 52 0.0015
952 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
953 DRUG INTERACTION 230 0.0014
954 ANGIOEDEMA 64 0.0014
955 LEUKOPENIA 72 0.0014
956 SUICIDE ATTEMPT 86 0.0014
957 DRUG WITHDRAWAL SYNDROME 124 0.0014
958 NEOPLASM PROGRESSION 49 0.0014
959 DEVICE LEAKAGE 61 0.0014
960 OVERDOSE 303 0.0014
961 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
962 EXPOSURE VIA SKIN CONTACT 36 0.0014
963 CARDIOVASCULAR DISORDER 35 0.0014
964 INTERSTITIAL LUNG DISEASE 66 0.0014
965 PRODUCT PRESCRIBING ERROR 32 0.0013
966 HEPATITIS 34 0.0013
967 SKIN BURNING SENSATION 94 0.0013
968 DIABETIC KETOACIDOSIS 31 0.0013
969 METABOLIC ACIDOSIS 41 0.0013
970 FEBRILE NEUTROPENIA 85 0.0013
971 ABORTION SPONTANEOUS 51 0.0013
972 DEVICE USE ERROR 44 0.0013
973 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
974 NEUTROPENIA 167 0.0012
975 MUCOSAL INFLAMMATION 32 0.0012
976 DEATH 1040 0.0012
977 PRODUCT ADHESION ISSUE 43 0.0012
978 C-REACTIVE PROTEIN INCREASED 43 0.0012
979 BREAST CANCER 102 0.0011
980 MALIGNANT NEOPLASM PROGRESSION 111 0.0011
981 TREATMENT FAILURE 85 0.0010
982 DRUG DOSE OMISSION BY DEVICE 80 0.0010
983 MATERNAL EXPOSURE DURING PREGNANCY 89 0.0010
984 COMA 43 0.0009
985 DEVICE EXPULSION 56 0.0009
986 PRODUCT STORAGE ERROR 69 0.0008
987 DEVICE DIFFICULT TO USE 44 0.0007
988 INTENTIONAL OVERDOSE 40 0.0006
989 PROSTATE CANCER 50 0.0006
990 DRUG DEPENDENCE 80 0.0005
991 TOXICITY TO VARIOUS AGENTS 76 0.0005
992 COMPLETED SUICIDE 35 0.0004